We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

229 hedge funds and large institutions have $2.8B invested in Clovis Oncology, Inc. in 2017 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

406% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 17

66% more capital invested

Capital invested by funds: $1.68B → $2.8B (+$1.12B)

40% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 55

37% more funds holding

Funds holding: 167 → 229 (+62)

36% more call options, than puts

Call options by funds: $100M | Put options by funds: $73.6M

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
229
Holders Change
+62
Holders Change %
+37.13%
% of All Funds
5.7%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
86
Increased
77
Reduced
55
Closed
17
Calls
$100M
Puts
$73.6M
Net Calls
+$26.5M
Net Calls Change
-$240K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$185M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$80.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$80.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$56.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$49.5M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$84.9M
2
PC
PointState Capital
New York
-$69.7M
3
NMC
NEA Management Company
Maryland
-$50.6M
4
SC
Samlyn Capital
New York
-$40.1M
5
RG
Redmile Group
California
-$39.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
76
Frontier Capital Management
Massachusetts
$4.62M +$4.41M +72,521 New
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
$4.6M +$407K +6,700 +10%
SIM
78
Spark Investment Management
New York
$4.57M +$4.36M +71,800 New
PP
79
PDT Partners
New York
$4.52M +$4.32M +71,047 New
Swiss National Bank
80
Swiss National Bank
Switzerland
$4.1M +$456K +7,500 +13%
PPA
81
Parametric Portfolio Associates
Washington
$3.98M +$2.26M +37,237 +148%
EI
82
EAM Investors
California
$3.69M +$3.52M +57,882 New
AQR Capital Management
83
AQR Capital Management
Connecticut
$3.63M +$3.46M +56,982 New
FHAM
84
Folger Hill Asset Management
New York
$3.57M +$3.4M +56,000 New
CCI
85
Columbus Circle Investors
$3.55M +$3.39M +55,819 New
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
$3.29M +$726K +11,939 +30%
GC
87
Guggenheim Capital
Illinois
$3.25M -$764K -12,569 -20%
Canada Pension Plan Investment Board
88
Canada Pension Plan Investment Board
Ontario, Canada
$3.2M +$559K +9,200 +22%
IHM
89
Iguana Healthcare Management
New York
$3.18M -$1.52M -25,000 -33%
ACM
90
Atika Capital Management
New York
$3.18M +$486K +8,000 +19%
BCPEM
91
Bain Capital Public Equity Management
Massachusetts
$2.92M +$2.79M +45,900 New
RhumbLine Advisers
92
RhumbLine Advisers
Massachusetts
$2.87M +$437K +7,196 +19%
SSA
93
Schonfeld Strategic Advisors
New York
$2.85M +$477K +7,844 +21%
Group One Trading
94
Group One Trading
Illinois
$2.75M +$2.46M +40,497 +1,519%
NFA
95
Nationwide Fund Advisors
Ohio
$2.73M +$273K +4,485 +12%
American Century Companies
96
American Century Companies
Missouri
$2.65M +$2.53M +41,629 New
UONDDL
97
University of Notre Dame du Lac
Indiana
$2.65M +$2.53M +41,625 New
Simplex Trading
98
Simplex Trading
Illinois
$2.63M +$1.96M +32,246 +353%
ACP
99
Acuta Capital Partners
California
$2.57M +$2.45M +40,361 New
Hudson Bay Capital Management
100
Hudson Bay Capital Management
Connecticut
$2.55M +$2.43M +40,000 New
2 3
4
5 6

CLVS Hedge Fund Activity: Q1 2017 in Review

229 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2017, worth a combined $2.8B — up 66% from $1.68B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CLVS positions and 17 closed out — a net gain of 69 holders — while 77 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock, adding an estimated $185M. The largest seller was Consonance Capital Management, cutting an estimated $84.9M.

  • 229 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2017, up from 167 in Q4 2016.
  • Funds reported $2.8B of Clovis Oncology, Inc. stock for Q1 2017, up 66% quarter-over-quarter.
  • 86 funds opened new Clovis Oncology, Inc. positions in Q1 2017 and 17 closed out, a net change of +69 holders.
  • The largest Clovis Oncology, Inc. buyer in Q1 2017 was BlackRock, an estimated $185M added.
  • The largest Clovis Oncology, Inc. seller in Q1 2017 was Consonance Capital Management, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2017.